Certus PV provides pre-approval and post-market pharmacovigilance (PV) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, medical devices and cosmetics.  Our offices are located in the Greater Toronto Area, in Oakville, Ontario.

Certus PV was recently acquired by Veristat, a clinical research organization (CRO) based outside of Boston, Massachusetts. Veristat’s broad expertise enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years’ experience in clinical trial planning and execution, Veristat is also committed to patient safety.

While Veristat is known for its dedication to patient safety throughout clinical trial planning, execution, and the regulatory approval process, Certus PV expands this safety expertise into post-marketing safety surveillance. New capabilities now available to Certus PV clients include a full suite of biometrics, medical writing, clinical operations, site management, medical affairs, regulatory affairs, and strategic consulting solutions, with a focus on therapeutic areas like oncology, rare disease, and infectious diseases.

Our experienced staff deliver PV services at all levels including specialist, senior consultant, strategic, and safety physician services.